![Colorectal Cancer Market](https://cdn.vantagemarketresearch.com/report/cover/Colorectal-Cancer-Market.webp)
Colorectal Cancer Market
Colorectal Cancer Market - Global Industry Assessment & Forecast
Segments Covered
By Therapy Targeted Therapy, Immunotherapy, Chemotherapy, Other Therapies
By Cancer Type Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Other Cancer Types
By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
![]() |
2023 |
![]() |
2024 - 2032 |
![]() |
2018 - 2022 |
![]() |
USD 11.9 Billion |
![]() |
USD 17.99 Billion |
![]() |
4.7% |
![]() |
Asia Pacific |
![]() |
North America |
Customization Offered
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Colorectal Cancer Market - Segment Analysis
- Overview
- Global Colorectal Cancer Market, 2016 - 2028 (USD Million)
-
Global Colorectal Cancer Market - by Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
-
Global Colorectal Cancer Market - by Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
-
Global Colorectal Cancer Market - by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
-
Global Colorectal Cancer Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Colorectal Cancer Market - Segment Analysis
- Overview
- North America Colorectal Cancer Market, 2016 - 2028 (USD Million)
-
North America Colorectal Cancer Market, by Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
-
North America Colorectal Cancer Market, by Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
-
North America Colorectal Cancer Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
-
North America Colorectal Cancer Market, by Country
- U.S.
- U.S. Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- U.S. Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- U.S. Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- U.S. Colorectal Cancer Market, By Therapy
- Canada
- Canada Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Canada Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Canada Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Canada Colorectal Cancer Market, By Therapy
- Mexico
- Mexico Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Mexico Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Mexico Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Mexico Colorectal Cancer Market, By Therapy
- U.S.
-
Europe Colorectal Cancer Market - Segment Analysis
- Overview
- Europe Colorectal Cancer Market, 2016 - 2028 (USD Million)
-
Europe Colorectal Cancer Market, by Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
-
Europe Colorectal Cancer Market, by Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
-
Europe Colorectal Cancer Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
-
Europe Colorectal Cancer Market, by Country
- Germany
- Germany Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Germany Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Germany Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Germany Colorectal Cancer Market, By Therapy
- UK
- UK Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- UK Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- UK Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- UK Market, By Therapy
- France
- France Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- France Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- France Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- France Colorectal Cancer Market, By Therapy
- Spain
- Spain Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Spain Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Spain Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Spain Colorectal Cancer Market, By Therapy
- Italy
- Italy Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Italy Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Italy Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Italy Colorectal Cancer Market, By Therapy
- BENELUX
- BENELUX Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- BENELUX Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- BENELUX Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- BENELUX Colorectal Cancer Market, By Therapy
- Rest of Europe
- Rest Of Europe Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Rest Of Europe Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Rest Of Europe Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Rest Of Europe Colorectal Cancer Market, By Therapy
- Germany
-
Asia Pacific Colorectal Cancer Market - Segment Analysis
- Overview
- Asia Pacific Colorectal Cancer Market, 2016 - 2028 (USD Million)
-
Asia Pacific Colorectal Cancer Market, by Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
-
Asia Pacific Colorectal Cancer Market, by Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
-
Asia Pacific Colorectal Cancer Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
-
Asia Pacific Colorectal Cancer Market, by Country
- China
- China Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- China Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- China Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- China Colorectal Cancer Market, By Therapy
- Japan
- Japan Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Japan Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Japan Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Japan Colorectal Cancer Market, By Therapy
- India
- India Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- India Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- India Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- India Colorectal Cancer Market, By Therapy
- South Korea
- South Korea Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- South Korea Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- South Korea Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- South Korea Colorectal Cancer Market, By Therapy
- South East Asia
- South East Asia Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- South East Asia Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- South East Asia Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- South East Asia Colorectal Cancer Market, By Therapy
- Rest of Asia Pacific
- Rest of Asia Pacific Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Rest of Asia Pacific Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Rest of Asia Pacific Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Rest of Asia Pacific Colorectal Cancer Market, By Therapy
- China
-
Latin America Colorectal Cancer Market - Segment Analysis
- Overview
- Latin America Colorectal Cancer Market, 2016 - 2028 (USD Million)
-
Latin America Colorectal Cancer Market, by Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
-
Latin America Colorectal Cancer Market, by Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
-
Latin America Colorectal Cancer Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
-
Latin America Colorectal Cancer Market, by Country
- Brazil
- Brazil Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Brazil Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Brazil Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Brazil Colorectal Cancer Market, By Therapy
- Argentina
- Argentina Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Argentina Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Argentina Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Argentina Colorectal Cancer Market, By Therapy
- Rest of Latin America
- Rest of Latin America Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Rest of Latin America Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Rest of Latin America Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Rest of Latin America Colorectal Cancer Market, By Therapy
- Brazil
-
Middle East & Africa Colorectal Cancer Market - Segment Analysis
- Overview
- Middle East & Africa Colorectal Cancer Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Colorectal Cancer Market, by Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
-
Middle East & Africa Colorectal Cancer Market, by Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
-
Middle East & Africa Colorectal Cancer Market, by Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
-
Middle East & Africa Colorectal Cancer Market, by Country
- GCC Countries
- GCC Countries Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- GCC Countries Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- GCC Countries Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- GCC Countries Colorectal Cancer Market, By Therapy
- South Africa
- South Africa Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- South Africa Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- South Africa Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- South Africa Colorectal Cancer Market, By Therapy
- Rest of Middle East & Africa
- Rest of Middle East & Africa Colorectal Cancer Market, By Therapy
- By Targeted Therapy
- By Immunotherapy
- By Chemotherapy
- By Other Therapies
- Rest of Middle East & Africa Colorectal Cancer Market, By Cancer Type
- By Colorectal Adenocarcinoma
- By Gastrointestinal Carcinoid Tumors
- By Other Cancer Types
- Rest of Middle East & Africa Colorectal Cancer Market, By Distribution Channel
- By Hospital Pharmacies
- By Retail Pharmacies
- By Online Pharmacies
- By Other Distribution Channels
- Rest of Middle East & Africa Colorectal Cancer Market, By Therapy
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Eli Lilly and Company (U.S.)
- Genentech Inc. (U.S.)
- Ipsen Biopharmaceuticals Inc. (U.S.)
- Merck Sharp & Dohme Corp. (U.S.)
- Pfizer Inc. (U.S.)
- Bayer AG (Germany)
- Bristol Myers Squibb Company (U.S.)
- Regeneron Pharmaceuticals Inc. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Taiho Pharmaceutical (Otsuka Pharmaceutical Co. Ltd.) (Japan)
- Novartis AG (Switzerland)
- Sanofi (France)
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Colorectal Cancer in terms of revenue?
-
The global Colorectal Cancer valued at USD 11.9 Billion in 2023 and is expected to reach USD 17.99 Billion in 2032 growing at a CAGR of 4.7%.
Which are the prominent players in the market?
-
The prominent players in the market are Eli Lilly and Company (U.S.), Genentech Inc. (U.S.), Ipsen Biopharmaceuticals Inc. (U.S.), Merck Sharp & Dohme Corp. (U.S.), Pfizer Inc. (U.S.), Bayer AG (Germany), Bristol Myers Squibb Company (U.S.), Regeneron Pharmaceuticals Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Taiho Pharmaceutical (Otsuka Pharmaceutical Co. Ltd.) (Japan), Novartis AG (Switzerland), Sanofi (France).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 4.7% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Colorectal Cancer include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Colorectal Cancer in 2023.